MENA Vaccine Market Growth, Analysis, Size, Share, Trends, Outlook 2025-2033

Vaccine Market in MENA 2025:

How Big is the MENA Vaccine Industry?

The MENA vaccine market size reached USD 2.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.7% during 2025-2033.

Market Statistics

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 2.3 Billion

Market Size in 2033: USD 3.8 Billion

Market Growth Rate (CAGR) 2025-2033: 5.7%

MENA Vaccine Market Trends and Drivers:

The market for MENA vaccines is expanding rapidly and this expansion is fueled by growing understanding of the important role that vaccines can play in desensitizing infectious disease and public healthissues1). Immunization campaigns in partnership with the government and the other work of the international health agencies (e.g., WHO, UNICEF) is leading to massive rises in vaccine coverage in the area. Specialised efforts at disease prevention, such as measles, poliomyelitis and hepatitis, have enabled routine immunisation at community level. Furthermore, the market is being further driven out from the pediatric immunizations by the demand for adult and travel immunizations. At the same time, the growing number of epidemic cascades, emerging diseases, and the push for increasing vaccination coverage of both countries in the area are now motivating them to adopt a more aggressive vaccination approach, which also brings into play conventional and new vaccines.

Technological momentum and growing market penetration of producers and pharmaceuticals from around the world are changing the market landscape. State-of-the-art vaccine platforms including mRNA and some viral vector platforms have revolutionized the paradigm of development and delivery process, such as that shown by the COVID-19 epidemic. These advances are further bolstering the field's capacity to prepare for future public health crises. Domestic vaccine production has the top priority of governments as a measure to give strength to supply chains and lessen the risk of import dependence. Public-private partnerships are driving speed of R&D and promoting greater diversity and economy in the vaccine portfolio. With the enhanced health care infrastructure and vaccine stock availability, the vaccine market in the Middle East and North America (MENA) region is expected to enjoy a lasting and substantial growth in the coming years.

MENA Vaccine Market Report Segmentation:

The report has segmented the market into the following categories:

Product Type Insights:

• Multivalent Vaccine
• Monovalent Vaccine

Treatment Type Insights:

• Preventive Vaccine
• Therapeutic Vaccine

Technology Insights:

• Conjugate Vaccines
• Inactivated and Subunit Vaccines
• Live Attenuated Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Others

Route of Administration Insights:

• Intramuscular and Subcutaneous Administration
• Oral Administration
• Others

Patient Type Insights:

• Pediatric
• Adult

Indication Insights:

A) Bacterial Diseases

• Meningococcal Disease
• Pneumococcal Disease
• Diphtheria/Tetanus/Pertussis (DPT)
• Tuberculosis
• Haemophilus Influenzae (Hib)
• Typhoid
• Others

B) Viral Diseases

• Hepatitis
• Influenza
• Human Papillomavirus (HPV)
• Measles/Mumps/Rubella (MMR)
• Rotavirus
• Herpes Zoster
• Varicella
• Japanese Encephalitis
• Rubella
• Polio
• Rabies
• Dengue
• Others

Distribution Channel Insights:

• Hospital Pharmacies
• Retail Pharmacies
• Institutional Sales
• Others

End User Insights:

• Hospitals
• Clinics
• Vaccination Centers
• Academic and Research Institutes
• Others

Country Insights:

• Saudi Arabia
• Turkey
• Israel
• United Arab Emirates
• Egypt
• Iran
• Iraq
• Qatar
• Algeria
• Kuwait
• Morocco
• Oman
• Others

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145